quantisnow
FeedTopReportsPricing
⌘K
Live feed
17:16:06·703d
NEWSRelease
Taro Pharmaceutical Industries Ltd. logo

Taro Pharmaceutical Indus Q4 Adj EPS $0.43 Beats $0.31 Estimate, Sales $164.941M Beat $156.062M Estimate

TARO· Taro Pharmaceutical Industries Ltd.
Health Care
Original source

Companies

  • TARO
    Taro Pharmaceutical Industries Ltd.
    Health Care

Recent analyst ratings

  • Jan 18UpdateH.C. Wainwright$43.00
  • Jan 31UpdateHC Wainwright & Co.$73.00
  • Jan 18UpdateHC Wainwright & Co.$75.00
  • Jul 28UpdateHC Wainwright & Co.$82.00

Related

  • SEC657d
    SEC Form 15F-12B filed by Taro Pharmaceutical Industries Ltd.
  • SEC668d
    SEC Form 25-NSE filed by Taro Pharmaceutical Industries Ltd.
  • PR668d
    Sun Pharma Completes Taro Merger
  • 13D/G668d
    Amendment: SEC Form SC 13D/A filed by Taro Pharmaceutical Industries Ltd.
  • SEC668d
    Amendment: SEC Form SC 13E3/A filed by Taro Pharmaceutical Industries Ltd.
  • SEC668d
    SEC Form 6-K filed by Taro Pharmaceutical Industries Ltd.
  • SEC700d
    SEC Form SC 13E3/A filed by Taro Pharmaceutical Industries Ltd. (Amendment)
  • NEWS700d
    Sun Pharmaceutical And Taro Pharmaceutical Industries' Merger Agreement Was Approved By The Affirmative Vote Of Taro Shareholders
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022